OraSure Technologies | OSUR - Current Liabilities


OraSure Technologies reported $25.12M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Agilent USD 2.27B 35M Mar/2026
AngioDynamics USD 71.96M 3.68M Sep/2025
Becton, Dickinson and Co. USD 9.4B 897M Jun/2026
Bio Techne USD 153.28M 12.85M Mar/2026
Bio-Rad Laboratories USD 961.3M 44.3M Jun/2026
Bruker USD 1.2B 150.4M Jun/2026
Cerus USD 100.8M 12.37M Dec/2025
Charles River Laboratories USD 1.13B 41.04M Jun/2026
Danaher USD 8.1B 645M Jun/2026
Dentsply International USD 1.18B 22M Jun/2026
Dexcom USD 2.36B 133.9M Jun/2026
Illumina USD 1.58B 12M Jun/2026
Integra LifeSciences USD 330.88M 15.96M Jun/2026
Intuitive Surgical USD 2.58B 65.1M Jun/2026
IQVIA Holdings USD 8.82B 486M Jun/2026
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Mettler Toledo International USD 1.2B 92.14M Jun/2026
Myriad Genetics USD 130.7M 500K Jun/2026
OraSure Technologies USD 25.12M 18.96M Jun/2026
Quidel USD 993.4M 31M Jun/2026
Repligen USD 132.66M 6.45M Jun/2026
Revvity USD 1.28B 37.71M Jun/2026
STAAR Surgical USD 73.39M 12.4M Jun/2026
Thermo Fisher Scientific USD 15.07B 448M Jun/2026
Trinity Biotech USD 141.21M 106.72M Dec/2025
Waters USD 2.27B 1.03B Mar/2026